<style face="normal" font="default" size="100%">In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro.</style>

Drupal-Bibcite

0<style face="normal" font="default" size="100%">In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro.</style><style face="normal" font="default" size="100%">In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro.</style>